Chronicle Pharmabiz: Zim Laboratories to be listed on BSE tomorrow

Nagpur based Zim Laboratories Limited, a leading provider of new drug delivery systems, will be listing on Bombay Stock Exchange (BSE) Main Board on June 8 and will have a price discovery as per trading on the bourses. It is likely to fetch attractive returns for existing shareholders.

The book value price of Zim Labs, promoted by technocrate Dr Anwar Daud is Rs 160 per equity share. Daud and his family has 54 per cent stake in ZIM Labs and the private equity partner Ashmore Alchemy India Advisors has about 22 per cent. Rest is with minority shareholders.

Original Article

Popular posts from this blog

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Lab announces approval for Vitamin D3 Orally Disintegrating Film

ZIM Laboratories’ Clonazepam Orally Disintegrating Strips Receive Market Approval